Article
Fluoroquinolone antibiotics are associated with an increased risk of blood glucose swings in diabetic patients, researchers reported.
Fluoroquinolone antibiotics are associated with an increased risk of blood glucose swings in diabetic patients, researchers reported.
In a large cohort study, the fluoroquinolones were linked to a heightened risk of both hypo- and hyperglycemia, compared with other antibiotic classes, according to Mei-Shu Lai, MD, PhD, and colleagues at the National Taiwan University in Taipei.
The risks were low -- observed in fewer than one in 100 patients studied -- but clinicians should be cautious when treating diabetic patients with fluoroquinolones, Lai and colleagues reported online in Clinical Infectious Diseases.
"Other antibiotics should be considered if dysglycemia is a concern," Lai and colleagues argued.
Read the full story here: http://bit.ly/1cFRT4B
Source: Med Page Today
How Can Employers Leverage the DPP to Improve Diabetes Rates?